Hemorrhoidal disease and chronic venous insufficiency: Concomitance or coincidence; results of the CHORUS study (Chronic venous and HemORrhoidal diseases evalUation and Scientific research)

被引:18
|
作者
Godeberge, Philippe [1 ]
Sheikh, Parvez [2 ]
Zagriadskii, Evgeny [3 ]
Lohsiriwat, Varut [4 ]
Montano, Abel Jalife [5 ]
Kosorok, Pavle [6 ]
De Schepper, Heiko [7 ]
机构
[1] Paris Descartes Univ, Mutualist Inst Montsouris, Dept Gastroenterol, Paris, France
[2] Saifee Hosp Mumbai, Dept Gastroenterol, Mumbai, Maharashtra, India
[3] Med Ctr ON CLIN, Dept Proctol, Moscow, Russia
[4] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok, Thailand
[5] Gen Hosp Mexico, Dept Proctol, Mexico City, DF, Mexico
[6] Iatros Med Ctr, Dept Proctol, Ljubljana, Slovenia
[7] Univ Hosp Antwerp, Dept Gastroenterol & Hepatol, Edegem, Belgium
关键词
chronic venous disease; hemorrhoidal disease; risk factors; PREVALENCE; GUIDELINES; MANAGEMENT; DISORDERS; CONSTIPATION; POPULATION; SYMPTOMS;
D O I
10.1111/jgh.14857
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim The CHORUS study (Chronic venous and HemORrhoidal diseases evalUation and Scientific research) was conducted to provide data on patients presenting with hemorrhoidal disease (HD) in clinical practice and to explore the frequency with which it coexists with chronic venous disease (CVD) and shared risk factors. Methods This international, noninterventional study enrolled adult patients attending a consultation for hemorrhoidal complaints. The questionnaire completed by physicians established the subjects' demographic and lifestyle characteristics and collected information on HD grade and symptoms and signs of CVD. Results A total of 5617 patients were analyzed. Symptoms commonly reported were bleeding (71.8%), pain (67.4%), swelling (55.0%), itching (44.1%), and prolapse (36.2%). Multivariate analysis revealed the variables with the strongest association with HD severity were older age, higher CVD CEAP (Clinical manifestations, Etiologic factors, Anatomic distribution of disease, and underlying Pathophysiology) class, constipation, and male gender (all P < 0.0001). Elevated BMI was a risk factor for HD recurrence. Among women, number of births had a significant association with both HD grade and recurrence. The presence of CVD, reported in approximately half the patients (51.2%), was strongly associated with advanced grade of HD (P < 0.0001). Treatments most commonly prescribed were venoactive drugs (94.3%), dietary fiber (71.4%), topical treatment (70.3%), analgesics (26.3%), and surgery (23.5%). Conclusions CHORUS provides a snap shot of current profiles, risk factors, and treatments of patients with HD across the globe. The coexistence of HD and CVD in more than half the study population highlights the importance of examining for CVD among patients with a hemorrhoid diagnosis, particularly when shared risk factors are present.
引用
收藏
页码:577 / 585
页数:9
相关论文
共 50 条
  • [1] ERCEVIT FORTE AND CHRONIC VENOUS INSUFFICIENCY - APPLICATION TO TREATMENT OF HEMORRHOIDAL PATHOLOGY
    CHEVREL, B
    MEDECINE & CHIRURGIE DIGESTIVES, 1980, 9 (07): : 647 - 650
  • [2] Chronic venous diseases and chronic venous insufficiency
    Mlacak, Blaz
    Ivka, Branimir
    Ladika, Rudolf
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2011, 80 (12): : 917 - 932
  • [3] Evaluation of hemorrhoidal disease and lower extremity venous insufficiency in primary adult varicocele: A prospective controlled study
    Aslan, Rahmi
    Erbin, Akif
    Celik, Sebahattin
    Ucpinar, Burak
    Sahinalp, Sahin
    Yildizhan, Murat
    Eryilmaz, Recep
    Taken, Kerem
    PHLEBOLOGY, 2019, 34 (09) : 621 - 626
  • [5] Concomitance of varicoceles and chronic venous insufficiency in young males
    Bolcal, C
    Sargin, M
    Mataraci, I
    Iyem, H
    Doganci, S
    Kilic, S
    Temizkan, V
    Demirkilic, U
    Tatar, H
    PHLEBOLOGY, 2006, 21 (02) : 65 - 69
  • [6] Clinical evidence and rationale of mesoglycan to treat chronic venous disease and hemorrhoidal disease: a narrative review
    Gallo, Gaetano
    Picciariello, Arcangelo
    Tufano, Antonella
    Camporese, Giuseppe
    UPDATES IN SURGERY, 2024, 76 (02) : 423 - 434
  • [7] Clinical evidence and rationale of mesoglycan to treat chronic venous disease and hemorrhoidal disease: a narrative review
    Gaetano Gallo
    Arcangelo Picciariello
    Antonella Tufano
    Giuseppe Camporese
    Updates in Surgery, 2024, 76 : 423 - 434
  • [8] SAFETY AND SECURITY OF DAFLON 500MG IN VENOUS INSUFFICIENCY AND IN HEMORRHOIDAL DISEASE
    MEYER, OC
    ANGIOLOGY, 1994, 45 (06) : 579 - 584
  • [9] A Study on Chronic Venous Insufficiency
    Riya
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2021, 9 (10): : 277 - 280
  • [10] Chronic venous insufficiency: Worldwide results of the RELIEF study
    Jantet, G
    ANGIOLOGY, 2002, 53 (03) : 245 - 256